[New indication areas for a neural therapeutic agent broadened by vitamin B12-b].
D001285:Atropine / Q000008:administration & dosage / Q000627:therapeutic use*; D001463:Barbiturates / Q000008:administration & dosage / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D006801:Humans; D006879:Hydroxocobalamin / Q000008:administration & dosage / Q000627:therapeutic use*; D007270:Injections, Intra-Articular; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D007592:Joint Diseases / Q000188:drug therapy*; D009437:Neuralgia / Q000188:drug therapy*; D009539:Nicotinic Acids / Q000008:administration & dosage / Q000627:therapeutic use*; D011343:Procaine / Q000008:administration & dosage* / Q000627:therapeutic use*; D011602:Psychophysiologic Disorders / Q000188:drug therapy*
D001463:Barbiturates; D009539:Nicotinic Acids; D011343:Procaine; D001285:Atropine; D006879:Hydroxocobalamin
Neue Indikationsbereiche für ein durch Vitamin-B12-b erweitertes Neuraltherapeutikum.